课题基金 / 基金详情

项目摘要

项目成果

Harold Phillip Koeffler的其他基金

相似基金

相关文献

中文摘要
翻译
提供空间。 Charles R.医学和科学德鲁大学(DREW)少数民族机构(MSL/HBCU)位于 南中洛杉矶,正计划与世界著名的琼森综合癌症的合作伙伴关系 加州大学洛杉矶分校(UCLA)的JCCC中心。与加州大学洛杉矶分校的合作计划- JCCC为开始加强DREW癌症研究和培训提供了一个独特的机会 基础设施演进相反,UCLA和JCCC的调查人员将有重要的机会, 重点解决与少数群体癌症负担不平等有关的问题。这 伙伴关系将侧重于癌症研究、培训、教育和外联领域,并加强 DREW和加州大学洛杉矶分校的研究组合,通过发展和提高能力的计划, 研究人员进行高质量的研究,对减少种族/民族差异具有敏感性, hcalth状态。此应用程序描述了我们的计划,建立一个全面的,无缝的联合计划, 癌症研究,培训和职业发展1)整合教师,研究员和学生到各种 癌症培训和职业发展计划; 2)规划和启动试点项目; 3)加强 DREW组织库的研究能力。 该计划将招募有前途的学生,科学家和临床医生在DREW和加州大学洛杉矶分校进入该领域, 癌症研究,教育和治疗,并保留这些人在合并DREW/加州大学洛杉矶分校 癌症项目与此同时,我们将增加少数民族科学家参与癌症研究的人数, 治疗、教育和培训。我们的培训和职业发展计划将产生杰出的 学术和文化敏感的学生,博士后研究员和教师。这些人将作为 我们的大使,以了解,因此,减少癌症的负担,在我们的服务不足, 社会经济弱势群体。 鉴于洛杉矶和该州人口结构的迅速变化, 伙伴关系是理想的,将有机会有一个积极的 i和少数民族和未受保护人口的生存。
英文摘要
SPACE PROVIDED. Charles R. Drew University of Medicine and Science (DREW) a minority institution (MSL/HBCU) located in South Central Los Angeles, is planning a partnership with the world renowned Jonsson Comprehensive Cancer Center (JCCC) at University of California Los Angeles (UCLA). The proposed partnership with the UCLA- JCCC provides a unique opportunity to begin to strengthen the DREW cancer research and training infrastructure. Conversely, UCLA and the investigators in the JCCC will have the important opportunity to address, in a focused manner, issues related to the unequal burden of cancer in minority populations. This partnership will focus on the areas of cancer research, training, education and outreach, and strengthen the DREW and UCLA research portfolios through programs that develop and enhance the capacity of investigators to perform high quality research with sensitivity toward reducing racial/ethnic disparities in hcalth status. This application describes our plans to establish a comprehensive, seamless program of joint cancer research, training and career development by 1) integrating faculty, fellows, and students into various cancer training and career development programs; 2) planning and initiating pilot projects; and 3) enhancing research capability of the DREW Tissue Repository. This program will recruit promising students, scientists, and clinicians at DREW and UCLA into the field of cancer research, education and treatment, and to retain these individuals within the combined DREW/UCLA cancer program. At the same time, we will increase the number of minority scientists in cancer research, treatment, education and training. Our training and career development programs will produce outstanding academic and culturally sensitive students, postdoctoral fellows, and faculty. These individuals will serve as our ambassadors toward understanding and therefore, reducing the burden of cancer in our underserved and sociocconomically disadvantaged populations. In view of the rapidly changing demographics of Los Angeles and the State Partnership is ideally situated and will have an opportunity to have a positive i and survival in minority and undcrserved populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
  • 批准号:
    9919544
  • 项目类别:
  • 资助金额:
    $36.31万
  • 财政年份:
    2016
  • 负责人:
    Harold Phillip Koeffler
  • 依托单位:
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
  • 批准号:
    9173247
  • 项目类别:
  • 资助金额:
    $36.31万
  • 财政年份:
    2016
  • 负责人:
    Harold Phillip Koeffler
  • 依托单位:
CCN Proteins and Breast Cancer
Pax5:Hematopoietic Transcription Factor Involved in ALL
  • 批准号:
    8449531
  • 项目类别:
  • 资助金额:
    $34.34万
  • 财政年份:
    2009
  • 负责人:
    Harold Phillip Koeffler
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: